Medical backcheck valves or injection port valves discussed herein generally relate to check valves for use with infusion lines and more specifically to needleless injection backcheck port valves that include pistons made from self-lubricated liquid silicone.
Needleless injection ports are frequently used in the medical industry for ready access to infusion lines. Broadly speaking, backcheck valves or needleless injection ports comprise quick-connect valves that permit medication or the like to be injected into infusion lines via a syringe and then close automatically when the syringe is withdrawn from the valve.
Representative prior U.S. Patents include U.S. Pat. Nos. 3,570,484, 3,831,629, 5,006,114, 5,049,128, 5,147,333, 5,201,725, 5,242,432, and 5,439,451. The contents of these patents are expressly incorporated herein by reference.
Regarding the needleless injection ports disclosed in U.S. Pat. No. 5,439,451, experience has shown that when a syringe is inserted into the injection port, the flexible elastomer piston 30 disclosed in the '451 patent occasionally sticks or does not readily re-seal upon withdrawing the syringe. Therefore, lubricant is typically added to the piston surface in the commercial embodiment to minimize friction between the piston 30 and the interior surface of the housing 10 to ensure proper seating of the main seal 68 and the conical shoulder 72 of the outer body 10 when the syringe is removed. However, adding a lubricant to the injection port involves an added step and negatively impacts the bottom line. In addition, the added step increases the risk of contamination to the valve and the risk of using a wrong lubricant.
Accordingly, there is a need for an improved piston that closes without the use of external lubricants.
According to the present invention, there is provided an injection port valve comprising a piston positioned inside a valve housing, the piston comprises a wall surface that comprises fluids emitted from within the wall surface to the wall surface. A spring may be positioned inside an interior cavity of the piston to urge the piston in a first position or the piston may be made with sufficient resiliency to function in the absent of the spring. A Luer nut attached to an opening of the valve housing, the Luer nut comprising at least one flow passage and a discharge nozzle defining a port; and wherein the valve housing further comprises a first nozzle defining an inlet opening, and wherein the inlet opening, the at least one flow passage, and the port of the discharge nozzle are in fluid communication when a syringe tip is inserted into the inlet opening. Optionally, the valve housing may include a second nozzle, which makes the valve a Y-site.
According to another aspect of the present invention, there is provided a method for making an injection port valve comprising inserting a plug into an upper piston section of a piston to form a piston assembly, the piston comprising a body section having an exterior surface, an upper piston section, a seal surface, and a piston cavity. The piston may be made by mixing a two-part liquid silicone rubber material and injecting the mixed two-part liquid silicone rubber material into a mold, and wherein the body section comprises a wall thickness that emits a medical lubricant to the exterior surface of the piston. The piston assembly can be inserted into an interior cavity of a valve housing and the valve housing may comprise a cylinder end and a first discharge nozzle. A spring can also be inserted into the piston cavity with a nut installed thereafter, wherein the nut comprising at least one flow passage and a discharge nozzle proximate the cylinder end of the valve housing.
Other alternatives and embodiments for implementing the injection port valves in accordance with the practice of the present invention are also described herein and further discussed below in the Detailed Description section.
These and other features and advantages of the present invention will become appreciated as the same becomes better understood with reference to the specification, claims and appended drawings wherein:
The detailed description set forth below in connection with the appended drawings is intended as a description of the presently preferred embodiments of the needleless injection port or backcheck valve (herein “valve”) provided in accordance with the present invention and is not intended to represent the only forms in which the present invention may be constructed or utilized. The description sets forth the features and the steps for constructing and using the valve of the present invention in connection with the illustrated embodiments. It is to be understood, however, that the same or equivalent functions and structures may be accomplished by different embodiments that are also intended to be encompassed within the spirit and scope of the invention. Also, as denoted elsewhere herein, like element numbers are intended to indicate like or similar elements or features.
The valve 10 is in the closed or sealed position when the piston 14 is in the natural uncompressed position shown in FIG. 1. In this sealed position, the valve 10 is sealed in a plurality of locations, which isolates the interior cavity of the valve from the exterior environment. At the inlet opening 20 of the nozzle 21, the upper seal 22 of the piston 14 is seated against the circumferential interior wall section 24 of the nozzle and the relative dimensions of the upper seal 22 and the diameter of the circumferential interior wall are such that the upper seal 22 is sufficiently compressed in the transverse direction to form a first seal point 25. For orientation purposes, the end near the nozzle 21 is the proximal end 15 and the end opposite the proximal end is the distal end 17.
Further distally from the inlet opening 20 at the juncture between the nozzle 21 and the housing mid-section 26, the middle seal 28 is seated against a shoulder 30. The cooperation between the middle seal 28 and the shoulder 30 provides a second seal point 29 for the valve assembly 10. Sufficient compression between the interface of the middle seal 28 and the shoulder 30 is provided by the spring force of the spring 32, which may vary depending on the spring constant chosen for the spring. Externally, the nozzle 21 may include a flat or smooth cylindrical surface (
Another sealing point is the seal 31 between the lower seal 34 of the piston 14 and the upper seal seat 36 of the nut 18. The seal 31 at this third location is adapted to seal the space occupied by the spring 32 from contamination by fluids dispensed from a syringe S (not shown) or from back flow, if any, from the infusion line. Although the three seal points 25, 29, 31 are discussed with specificity, more number or less number of seals may be incorporated in the valve 10 without deviating from the scope of the present invention.
The piston 14 may be made from a self-lube liquid silicone rubber, which is commercially available from Nusil Silicone Technology of Santa Barbara, Calif. The self-lube silicone rubber is a translucent, two-part system designed for liquid injection molding. When A and B components are mixed together, which are sold by Nusil Silicone Technology in a two-part kit, in equal portions, the liquid will cure to a tough, rubbery elastomer via addition-cure chemistry. After about sixty minutes of molding elapsed time, the cured silicone rubber will begin to self-lubricate a silicone fluid from within the wall to the piston surfaces. The fluid flows from within the wall to the interior and exterior surfaces of the piston 14 whenever the piston 14 is stressed or squeezed, such as when the piston 14 is compressed and released within the valve housing 12. As the piston 14 exudes lubricant to the surfaces, the mass or density of the piston reduces approximately an equal amount.
The fluid level or fluid flow to the surfaces can be adjusted with a formulation modification, such as by varying the ratio of component A and component B. Durometers available are 15, 30, 40, 50, and 60 with a range of high and low level of bleed out for each of the durometer range. In one embodiment, the piston has the following physical properties: about 1.15 specific gravity with a range of about 1.1 to about 1.2 being acceptable; a 50 durometer Shore A with an acceptable range of about 40 to about 60 durometer; at least 600 psi minimum tensile strength with about 800 psi minimum being more preferred; an elongation rating of about 275% minimum with about 350% minimum being more preferred; and a tear strength of about 100 ppi (pounds per inch) minimum with 125 ppi being more preferred.
Part A of the two-part component includes a noble metal catalyst based on platinum, although palladium and rhodium may be also be used. Part B of the two-part component includes a silicone hydride-functional cross-linker, polydimethyl siloxane polymer, and internal lubricant, which is medical grade fluorosilicone fluid. The two-part system is pumped directly into a mixer on an injection molding machine for homogenization and then directly into mold cavities. Vulcanization or curing occurs rapidly within the heated mold cavity, which is in the temperature range of about 245 to 485 degrees F.
Instead of liquid injection molding, a blend of high consistency silicone rubber may also be used to make the piston 14 using the same A/B materials discussed above. High consistency rubber may be mixed or blended together outside of a mold. A mill may be used for catalyzation of the two part components. The catalyzed material can pass through the mill several times until it is homogeneous then removed in sheet form. After milling, the material is cut or shaped into a preform that can be easily fed into a heated compression or transfer mold where the vulcanization takes place. The raw materials used in the present process are essentially the same as that used in the liquid silicone material except that a peroxide catalyst is used in the high consistency rubber.
The formed piston 14 has a consistency of a flexible or soft rubber and the like. As such, when the piston 14 is assembled inside the housing 12, the plug 16 is used to reinforce the upper piston section 38 of the piston. In particular, the upper stem section 40 of the plug 16, which is sized to fill the space of the upper piston section 38, is used to provide reinforcement for the upper piston section 38 of the piston 14. Alternatively, the piston 14 may be formed with a tough consistency having a resiliency that allows it to self-expand upon removal of the syringe S from the nozzle 21 without a spring. This may be accomplished, for example, by increasing the durometer of the piston material, varying the piston wall thickness along the length of the piston, and providing additional sealing points between the piston 14 and the interior cavity 64 of the housing 12.
The plug 16 is secured to the upper piston section 38 of the piston at the top by a head section 42 and at the bottom by attaching the plug tail 44 with a snap ring 46. The plug tail 44 and the snap ring 46 engage one another by way of a detent engagement, which may alternatively include friction engagement, adhesive, and the like. The snap ring 46 may be sized such that the spring 32 is capable of sliding over the snap ring and abut a flange section 48 of the snap ring. However, other engagement means, such as using a cylindrical ring, a threaded nut and the like to engage the plug, may be incorporated.
The piston 14 and the spring 32 are both in contact at their distal ends by the nut 18. The nut 18 includes an upper seal seat 36, as previously discussed, a raised floor 50 adjacent thereto, and a circular channel 52 for locating the distal end of the spring 32. A central projection 54 may be utilized to project into the central space of the spring 32 to assist in maintaining the alignment between the distal end of the spring and the circular channel 52. The nut 18 may be secured to the housing 12 via bonding the radially extending flange 56 to the perimeter end 58 of the housing. The bonding may include adhesive or bonding agent, may include sonic seal welding, and the like, such as a threaded engagement.
A discharge nozzle 60, which defines a lumen or port 62, extends from the distal end of the nut 18. The lumen or port 62 is in communication with the interior cavity via two spaced apart liquid passages 66, with any number of liquid passages being suitable so long as friction loss is accounted for. The liquid passages 66 provide fluid pathways for fluids dispensed from a syringe S to travel and flow out of the nozzle 60, as further discussed below. The nut 18 further includes two optional vent holes (See, e.g., vent holes 116 in
The valve 10 is preferably sized with standardized sizes. For example, the nozzle 21 and the threaded skirt section 70 may be made to attach with standard syringes and fittings for common medical applications, such as ISO standards 594/1 and 594-2 for Luer tapered fittings. The Nut 18, housing 12, plug 16, and snap ring 46 are preferably made from polycarbonate material in either clear, colored, and/or white finish, which may alternatively be made from nylon, polyethylene, polypropylene, acrylic, or their equivalents. The spring 32 is preferably made of stainless steel, such as a 316 or 302 stainless steel.
To facilitate fluid flow through the interior cavity 64 of the valve 10, upper flow channels 78 and lower flow channel 80 are incorporated. The upper flow channels 78 may include one or more channels and preferably comprises 4 to 12 channels and more preferably 8 channels. Similarly, the lower flow channels 80 may include one or more channels and preferably comprises 4 to 12 channels and more preferably 8 channels. Both the upper 78 and lower flow channels 80 are molded into the interior surface of the interior cavity 64. Thus when a syringe is inserted into the valve 10 to introduce fluids to the infusion line via the valve, the fluids may travel along the flow channels 78, 80 to the liquid passages 66 of the nut 18 and out the discharge nozzle 60. The channels 78, 80 are incorporated so that as the piston 14 is compressed by the syringe to expose the inlet opening 20 and the piston expands to block the interior cavity 64 of the housing 12, the channels provide open pathways for the fluids to flow through to the discharge nozzle 60.
The head section 42 of the plug 16 includes two plug flow channels 82 in a crucifix configuration. The flow channels are incorporated so that as the tip of the syringe is positioned against head section 42 of the plug 16, gaps are provided by the flow channels 82 to allow fluids to flow from the syringe. Alternatively, a plurality of parallel channels may be used or one wide channel instead of multiple smaller channels to accomplish the same flow function.
An optional valve cover 84 comprising a valve cover base 86 removably attached to the nut skirt 72 may be incorporated for sanitation, packaging, and/or shipping. The valve cover 84 may have a cylindrical shape or may have a tapered top section 88 and a closed top 90 as shown in FIG. 1.
Referring now to
The assembled valve gut (2B) is then inserted into the valve body 12 (2C) by way of the lower opening 100 of the housing 12. A small tool (not shown), such as a plastic rod or a metal rod, may be used to assist in the insertion of the valve gut 98 into the valve housing and into the nozzle section 21 of the valve body. The spring 32 is then inserted into the spring chamber 68 of the piston by way of the lower opening 96 of the piston 14. Finally, the nut 18 is positioned at the lower opening 100 of the housing 12 so that the radially extending flange 56 abuts against the perimeter end 58 of the housing. The nut 18 may be bonded to the housing 12 by sonic welding, or by gluing.
Also shown is a pair of positioning members 74, which may include circumferential protuberances formed on the nut 18 to firmly position the nut 18 within the interior wall surface of the skirt 76 of the valve housing 12. Alternatively, instead of incorporating two or multiple positioning members 74, the entire mid-section 102 of the Nut 18 may be sized to firmly position within the interior wall surface of the skirt. Both the piston 14 and the valve housing 12 comprise a draft angle of about 0.3 degree to about 5 degrees. However, for purposes of the following disclosure, the term cylindrical housing section may be used, which is understood to include a piston or a valve body section that has a slight draft or tapered angle. In one embodiment, the draft angle of the piston 14 is 1 degree per side, the inside of the housing 12 body is 0.5 degree, and the female Luer taper 18 is 0.060 inch per inch.
Turning now to
The interior cavity 64 includes an interior cavity diameter D. In the normal uncompressed position (FIG. 1), the piston 14 has a cross-sectional diameter that is less than D. However, as the piston 14 is activated or compressed by the syringe S (FIG. 3), the piston wall 108 crumbles and compresses in reaction thereto. Since the piston 14 is preferably practiced without pre-formed crumble zones or regions along the piston wall, the piston wall randomly crumbles and collapses with certain portions of the wall expanding and certain portions of the wall collapsing in unpredictable fashions.
The portions of the piston wall 108 that expand to contact the cavity diameter D would normally obstruct the fluids F flowing from the syringe S. However, because the interior cavity 64 includes lower flow channels 80, the obstruction is mitigated as the channels provide open passages for the fluids F. The same is true for the upper flow channels 78 located in the nozzle section 21 of the valve housing 12. Once the fluids F flow past the upper channels 78 and the lower channels 80, they flow into the plurality of liquid passages 66 located in the nut 18 and then out the port 62 of the discharge nozzle 60. Although not shown, fluids that leave the discharge nozzle 60 flow into an infusion line connected to the threaded skirt section 70 of the valve 10.
Upon completing the infusion process and removal of the syringe S from the nozzle 21, the spring 32 releases to expand the piston 14, which then causes the first and second seal joints 25, 29 to be reestablished. As the piston 14 is formed from a self-lubricated silicone material, little resistance or friction is encountered during the expansion process. As previously discussed, liquid silicone exudes to the surface of the piston 14 to minimize friction between the interface of the piston and the valve housing 12. The valve 10, thus, provides a quick access injection site that is reliable and safe to use.
Turning now to
In the embodiment shown, the valve housing 12′ includes a second nozzle 112 extending from a side of the housing. The second nozzle 112 includes a nozzle axis that is positioned at an angle θ from the axis of the first nozzle 21′, which may range anywhere from about 10 to about 90, with about 25 to about 65 being more preferred. The second nozzle 112 defines a port or lumen 114 that is in communication with the port or lumen 62′ of the discharge nozzle 60′ via the interior cavity 64′ and the liquid passages 66′ located in the nut 18′. In practice, the second nozzle 112 is preferably used for IV infusion, such as for hooking to a salient solution container, and the first nozzle 21′ is preferably used for introducing supplemental medication or other fluids. Thus, while the first nozzle 21′ includes a plurality of seal joints for sealing the valve 110 from the exterior environment, the second nozzle 112 has a constant open configuration with the port 62′ of the discharge nozzle 60′. In other words, during infusion of fluids into the valve 110 from a syringe S (not shown) via the first nozzle 21′, solutions or fluids may also flow into the valve 110 from the second nozzle 112.
The nut 18′ is shown with a threadless skirt section 118 and a discharge nozzle length that is longer relative to the discharge nozzle length of the nut 18 of FIG. 1. This modified nut configuration is adapted to frictionally engage an infusion line rather than threading to a fitting to provide a relatively quicker connect/disconnect with the infusion line. The modified configuration may be used by sliding an open end of the infusion line over the discharge nozzle 60′ until the end of the infusion line engages the threadless skirt section 118. Alternatively, a pre-assembled infusion line may be incorporated with the valve 110 by assembling an infusion line over the discharge nozzle 60′ and solvent bond the connection. However, the nut 18 from
Although the preferred embodiments of the invention have been described with some specificity, the description and drawings set forth herein are not intended to be delimiting, and persons of ordinary skill in the art will understand that various modifications may be made to the embodiments discussed herein without departing from the scope of the invention, and all such changes and modifications are intended to be encompassed within the appended claims. Various changes to the valves may be made including manufacturing the dimensions differently, using different materials, changing the interface between the various components to include ridges and channels, etc. For example, instead of having flat seal joints, the surfaces may be serrated, the number of flow channels may be modified, and the snap ring may simply be a cylindrical ring. Other changes may include incorporating a smooth inlet nozzle instead of a threaded nozzle, adding colors to the valve finishes, changing the shape of the housing and of the piston, and using the valve in non-medical related industries, such as in food processing, chemical processing, etc. Still alternatively, other medical lubricant may be used instead of liquid silicone to lubricate the piston surfaces and using similar blend or mixture to create a piston wall that exudes medical lubricant from inside the wall to the wall surfaces. Accordingly, many alterations and modifications may be made by those having ordinary skill in the art without deviating from the spirit and scope of the invention.
Number | Name | Date | Kind |
---|---|---|---|
3570484 | Steer et al. | Mar 1971 | A |
3806086 | Cloyd | Apr 1974 | A |
4883467 | Franetzki et al. | Nov 1989 | A |
4934655 | Blenkush et al. | Jun 1990 | A |
4953594 | Von Berg | Sep 1990 | A |
5104389 | Deem et al. | Apr 1992 | A |
5163922 | McElveen, Jr. et al. | Nov 1992 | A |
5190523 | Lindmayer | Mar 1993 | A |
5203775 | Frank et al. | Apr 1993 | A |
5230706 | Duquette | Jul 1993 | A |
5242393 | Brimhall et al. | Sep 1993 | A |
5242423 | Goodsir et al. | Sep 1993 | A |
5251873 | Atkinson et al. | Oct 1993 | A |
5269771 | Thomas et al. | Dec 1993 | A |
5289849 | Paradis | Mar 1994 | A |
5322516 | Brugger | Jun 1994 | A |
5336174 | Daoud et al. | Aug 1994 | A |
5353837 | Faust | Oct 1994 | A |
5360413 | Leason et al. | Nov 1994 | A |
5390898 | Smedley et al. | Feb 1995 | A |
5395348 | Ryan | Mar 1995 | A |
5401245 | Haining | Mar 1995 | A |
5409463 | Thomas et al. | Apr 1995 | A |
5251873 | Atkinson et al. | May 1995 | A |
5423791 | Bartlett | Jun 1995 | A |
5425465 | Healy | Jun 1995 | A |
5439451 | Collinson et al. | Aug 1995 | A |
5441487 | Vedder | Aug 1995 | A |
5509433 | Paradis | Apr 1996 | A |
5533983 | Haining | Jul 1996 | A |
5535785 | Werge et al. | Jul 1996 | A |
5540661 | Tomisaka et al. | Jul 1996 | A |
5549577 | Siegel et al. | Aug 1996 | A |
5569235 | Ross et al. | Oct 1996 | A |
5573516 | Tyner | Nov 1996 | A |
5584808 | Healy | Dec 1996 | A |
5616129 | Mayer | Apr 1997 | A |
5620434 | Brony | Apr 1997 | A |
5624414 | Boettger | Apr 1997 | A |
5645538 | Richmond | Jul 1997 | A |
5674206 | Allton et al. | Oct 1997 | A |
5676346 | Leinsing | Oct 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5699821 | Paradis | Dec 1997 | A |
5730418 | Feith et al. | Mar 1998 | A |
5743894 | Swisher | Apr 1998 | A |
RE35841 | Frank et al. | Jul 1998 | E |
5782816 | Werschmidt et al. | Jul 1998 | A |
5785693 | Haining | Jul 1998 | A |
5788215 | Ryan | Aug 1998 | A |
5806551 | Meloul et al. | Sep 1998 | A |
5806831 | Paradis | Sep 1998 | A |
5810793 | Boettger | Sep 1998 | A |
5848994 | Richmond | Dec 1998 | A |
5873862 | Lopez | Feb 1999 | A |
5879327 | Moreau DeFarges et al. | Mar 1999 | A |
5901942 | Lopez | May 1999 | A |
5921264 | Paradis | Jul 1999 | A |
5921419 | Niedospial, Jr. et al. | Jul 1999 | A |
5928204 | Lopez | Jul 1999 | A |
5957898 | Jepson et al. | Sep 1999 | A |
5967490 | Pike | Oct 1999 | A |
6029946 | Doyle | Feb 2000 | A |
6036171 | Weinheimer et al. | Mar 2000 | A |
6039302 | Cote, Sr. et al. | Mar 2000 | A |
6040366 | Burkus et al. | Mar 2000 | A |
6045534 | Jacobsen et al. | Apr 2000 | A |
6063062 | Paradis | May 2000 | A |
6068011 | Paradis | May 2000 | A |
6106502 | Richmond | Aug 2000 | A |
6113068 | Ryan | Sep 2000 | A |
6117114 | Paradis | Sep 2000 | A |
6127320 | van Ooij et al. | Oct 2000 | A |
6132403 | Lopez | Oct 2000 | A |
6142446 | Leinsing | Nov 2000 | A |
6168137 | Paradis | Jan 2001 | B1 |
6170800 | Meloul et al. | Jan 2001 | B1 |
6228069 | Barth et al. | May 2001 | B1 |
6245048 | Fangrow, Jr. et al. | Jun 2001 | B1 |
6245056 | Walker et al. | Jun 2001 | B1 |
6261282 | Jepson et al. | Jul 2001 | B1 |
6273869 | Vaillancourt | Aug 2001 | B1 |
6290206 | Doyle | Sep 2001 | B1 |
6299131 | Ryan | Oct 2001 | B1 |
6299132 | Weinheimer et al. | Oct 2001 | B1 |
6344033 | Jepson et al. | Feb 2002 | B1 |
6364869 | Bonaldo | Apr 2002 | B1 |
6428520 | Lopez et al. | Aug 2002 | B1 |
6482188 | Rogers et al. | Nov 2002 | B1 |
6491668 | Paradis | Dec 2002 | B1 |
6541802 | Doyle | Apr 2003 | B2 |
RE38145 | Lynn | Jun 2003 | E |
6572592 | Lopez | Jun 2003 | B1 |
6616627 | Willis et al. | Sep 2003 | B2 |
6626418 | Kiehne | Sep 2003 | B2 |
6641561 | Hill et al. | Nov 2003 | B1 |
6645170 | Landau | Nov 2003 | B2 |
6669673 | Lopez | Dec 2003 | B2 |
6669681 | Jepson et al. | Dec 2003 | B2 |
6682509 | Lopez | Jan 2004 | B2 |
6706022 | Leinsing et al. | Mar 2004 | B1 |
20030032940 | Doyle | Feb 2003 | A1 |
20030060779 | Richmond | Mar 2003 | A1 |
20030136932 | Doyle | Jul 2003 | A1 |
Number | Date | Country | |
---|---|---|---|
20040195538 A1 | Oct 2004 | US |